Podcasts about Diabetes Care

What happened at ADA? It's not the research or the science, but the response to a protest that's been getting the biggest headlines. My guest, Dr. Desmond Schatz was scheduled to come on the podcast this week to talk about early, population-level screening for type 1 diabetes. Dr. Schatz was one of the five people asked to leave the ADA conference after passing out an editorial. The ADA has sinced apologized a coupe of times.. you'll hear the whole story form Dr. Shatz, we'll get into the follow up since our conversation, and we do talk about screening. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Apology from ADA president Chuck Henderson: https://www.youtube.com/watch?v=W7K2j3Rs-Qg The Diabetes Care editorial published in April and handed out at ADA (click here) The second Diabetes Care editorial published in June (click here)  More about this story and the resignations here: https://conexiant.com/endocrinology/articles/ada-leaders-resign-amid-researcher-ejections/ Learn about our in-person events here: https://diabetes-connections.com/events/  Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Physicians and former prisoners want inmates to have access to continuous glucose monitors, insulin pumps and better diabetes education while incarcerated.

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. 4:05 Our hosts speak with Anna Kahkoska, MD, PhD, Joan Heckler Gillings Assistant Professor in the Department of Nutrition and adjunct assistant professor of medicine in the Division of Endocrinology and Metabolism at the University of North Carolina at Chapel Hill, as well as Joshua Niznik, PharmD, PhD, assistant professor in the Division of Geriatric Medicine within the UNC School of Medicine. Their article, "Qualitative Analysis of Patient Portal Messages From Older Adults With Type 2 Diabetes," is available at doi.org/10.2337/doc25-0079. 14:10 Our hosts introduce Esben Thyssen Vestergaard, PhD, clinical associate professor in the Department of Clinical Medicine and Department of Pediatrics Aarhus University in Aarhus, Denmark. His article, "Clinic for Athletes With Type 1 Diabetes: Evaluation of a Structured Clinical Care Model for Physically Active Individuals," is available for free at doi.org/10.2337/doc25-0064. 21:40 Finally, Richard and Jane highlight some of their favorite articles from the May-June issue. Rezaeiahari, et al. Rural–Urban Differences in Use of Diabetes Self-Management Education and Support in Arkansas, 2015–2019 doi.org/10.2337/doc25-0065 Liu, et al. Trends in Nutrient Intake Among U.S. Adults by Diabetes Status: National Health and Nutrition Examination Survey 2011–2020 doi.org/10.2337/doc25-0076 Yanez Bello, et al. Barriers to the Adoption of Diabetes Technologies and the Implementation of Connected Insulin Pens in a Largely Minority Population With Type 1 Diabetes doi.org/10.2337/doc25-0072 Shehab, et al. Barriers to Effective Type 2 Diabetes Care in a Conflict-Affected Region of Syria: A Qualitative Study of Health Care Provider Perspectives doi.org/10.2337/doc26-0021 ElSayed, et al. Enhancing Physician Clinical Competency: A Cluster Randomized Trial of a Multimodal Online Educational Program in a Multinational Diabetes Workforce doi.org/10.2337/doci25-0007 Olesen, et al. A Danish Nationwide Cohort of Foot Health in Individuals With Diabetes From the Danish Foot Status Database doi.org/10.2337/doc26-0002 To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

Send us Fan MailThe liver is the only organ in the body that can release stored glucose to prevent low blood sugar. So why has injected insulin never been able to reach it?In this clip from our episode “Finding a Solution for GLP-1 Side Effects”, host David E. Williams and Bob Geho, Founder and CEO of Diasome, break down the biological gap at the heart of diabetes treatment and how a father's decades of research into liver-targeted insulin delivery became the founding idea behind Diasome.

AP correspondent Julie Walker reports attorneys urge the release of a mosque leader, saying he's been denied diabetes care in ICE custody.

Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.

Welcome to the latest episode (June 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Update: Shah S, et al. "Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort Diabetes Care. 2026;49(6):1067–1077. doi.org/10.2337/dc25-2727 Hespanhol L, et al. "Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis." Diabetes Care. 2026;49(6):1134–1143. doi.org/10.2337/dc25-2435 Tatum K, et al. "Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer." JAMA. Published Online: May 11, 2026 2026;9;(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133 Winkler C, et al. "Screening Children for Early-Stage Type 1 Diabetes." JAMA. Published Online: May 21, 2026 doi:10.1001/jama.2026.6085 Würtz Yazdanfard P, Kosjerina V, Wood-Kurland H et al. "Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024)" Lancet. Volume 66, 101716, July 2026. doi:10.1016/j.lanepe.2026.101716 Horn D, Aronne L, Wharton S et al. "Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial." Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00656-2 Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health For information about the American Diabetes Association's scholarly journals, visit diabetesjournals.org. For more about this podcast, click here.

Elisa Martinez, N.P. discusses the role of cultural sensitivity and language in improving patient outcomes with diabetes and insulin management. She shares the value in practical phrasing and motivational approaches to helping patients adhere to treatment. She highlights the importance of reducing diabetes stigma to help enhance patient outcomes.To schedule with Elisa Martinez, NP 

The live phone-in programme “Hello Doctor” by the Diabetes Care Foundation of India featured expert guidance from Dr. Sunil Gupta and Dr. Shlok Gupta on diabetes awareness, diagnosis, prevention, and treatment. During the discussion, Dr. Sunil Gupta highlighted the alarming rise of diabetes and prediabetes in India. Referring to recent health data, he explained that nearly every fourth adult above 18 years of age is affected by either diabetes or prediabetes. He emphasized that many people remain undiagnosed for years because diabetes often develops without noticeable symptoms. The experts stressed the importance of regular health check-ups, especially after the age of 35, or earlier in people with a family history of diabetes. They explained the role of HbA1c testing, fasting blood sugar, and oral glucose tolerance tests in diagnosing diabetes and prediabetes. Dr. Gupta also discussed how obesity, genetics, sedentary lifestyle, and poor eating habits increase diabetes risk. He warned against self-medication and explained that diabetes treatment must be individualized based on factors such as body weight, insulin production, and insulin resistance. Dr. Shlok Gupta explained that very high blood sugar levels can temporarily exhaust insulin-producing beta cells. In such cases, short-term insulin therapy may help the pancreas recover before shifting patients back to oral medicines. The programme also highlighted modern diabetes technologies such as Continuous Glucose Monitoring (CGM) systems and insulin pumps, which help patients monitor and control blood sugar more effectively. Expert- Dr Sunil Gupta & Dr Shlok Gupta Anchor- Purva Kulkarni Podcast: 24/04/2026 Recorded at: Akashwani Nagpur

Outside of pregnancy, guidelines emphasize diabetes self-management education and support to facilitate informed decision making, self-care behaviors, problem solving, and active collaboration with health care professionals. This includes, in those with good health literacy, the concept of patient-led self-titration of basal insulin results which has data that it improves glycemic management compared with clinician-led titration for type 2 diabetes among nonpregnant adults. But what about for GDM? Can patient's self manage their BASAL insulin? In this episode, we will review a new RCT published in April 2026 in the Green Journal on this very subject. As novel as this is, it is not the first to report on this as it was also published (retrospective study in the UK) in 2022. This is a novel approach to insulin in GDM but there are some questions that remain. Listen in for details.1. Boonpattharatthiti K, Wechkunanukul K, Mayang N, et al . Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.Diabetes Care. 2025. 2. Valent, Amy M. DO, MCR; Barbour, Linda A. MD, MSPH. Insulin Management for Gestational and Type 2 Diabetes in Pregnancy. Obstetrics & Gynecology 144(5):p 633-647, November 2024. | DOI: 10.1097/AOG.00000000000056403. Wang, Xiao-Yu MD; Gabbe, Steven MD; Landon, Mark B. MD; Venkatesh, Kartik K. MD, PhD et al. Patient-Led Insulin Titration for Glycemic Management With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstetrics & Gynecology 147(4):p 501-509, April 2026. 4. McGovern AP, Hirwa KD, Wong AK, et al. Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight. Diabet Med. 2022;39:e14926. doi: 10.1111/dme.14926

The live phone-in programme “Hello Doctor” by the Diabetes Care Foundation of India featured Dr. Sunil Gupta and Kavita Gupta, who shared valuable insights on diabetes, common myths, healthy nutrition. and proper treatment. Dr. Sunil Gupta explained that self-medication or following advice from neighbours and relatives can be dangerous, as every diabetes patient requires personalized treatment based on age, weight, blood pressure, heart, kidney and liver health, family history, and his own lifestyle. He further highlighted the dangers of alcohol, which can damage the pancreas and lead to secondary diabetes, sometimes requiring lifelong insulin. Kavita Gupta clarified that “sugar-free” does not mean “calorie-free.” Such foods may still contain fat or artificial sweeteners and can increase blood sugar and weight if consumed excessively. She advised limiting sweets and avoiding energy drinks and sugary beverages, especially for children. The experts recommended healthier options like buttermilk, coconut water, lemon water, and mango panna. They also emphasized eating three main meals and three small snacks to avoid weakness caused by long gaps between meals. Expert- Dr Sunil Gupta & Dr Kavita Gupta Anchor- Swati Huddar Podcast : 10/04/2026 Recorded at: Akashwani Nagpur

Rob sits down with Dr. Gregory Dodell, an endocrinologist from New York City and one of the more honest voices in the diabetes space online. What starts as a conversation about why a doctor would bother making Instagram videos turns into something a lot more real, a candid look at what actually happens between patients and their providers, why those relationships succeed or fall apart, and what it takes to feel like a full person inside a system that was mostly built around numbers. Dr. Dodell talks about the thing he keeps learning from patients that wasn't in any textbook: stress. How it silently drives blood sugars up, how burnout and over-fixation on every CGM reading can quietly hollow out your quality of life, and why a slightly elevated number is sometimes worth it if it means you actually got to live your day.  It's not a permission slip to ignore your management. It's a reminder that the goal was never the A1C itself. The goal was always life on the other side of it. They also dig into the infrastructure problems that make good diabetes care so hard to deliver, the prior authorization nightmare, the endocrinologist shortage, and the 20-patient days that leave almost no room to actually sit with someone.  Dr. Dodell shares, for the first time publicly, that he's moving toward concierge primary care, not out of ambition, but out of frustration with a system that makes it structurally almost impossible to do the job he trained for. If you've ever left an endo appointment feeling like you only got halfway through what you needed to say, or worse, left feeling judged, this one's for you. Chapters: 00:00   Who is Dr. Gregory Dodell? 01:41   Why HCPs Are Becoming Content Creators 04:06   Reaching Patients Beyond the Office 05:16   Preparing for Short, High-Stakes Endo Visits 06:29   Fitting Everyone Into One Box Doesn't Work 07:18   Listening First — How to Read the Room 08:26   The Surprising Role of Stress on Blood Sugar 09:59   Diabetes Distress and Over-Fixation on Numbers 10:35   Quality of Life vs. Perfect Blood Sugar Control 11:37   There's More to Life Than an In-Range Number 13:33   Complications — Compassion Over Judgment 14:59   Stigma, A1Cs, and the Morality Trap 16:03   How Patients Have Been Traumatized by Healthcare 17:37   The Endocrinologist Shortage Crisis 20:04   Prior Authorizations — A System-Wide Failure 24:38   Dream Scenario: What Ideal Diabetes Care Looks Like 26:10   Concierge Medicine and the Future of the Endo Practice (First Announcement) 28:44   Exciting Research — T-ZELD, GLP-1s, Autoimmune Breakthroughs 32:47   How to Find and Advocate for Yourself with Your Endo Resources: * Dr. Gregory Dodell on Instagram (@EverythingEndocrine) * Central Park Endocrinology

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, join Over the Counter to discuss the modern push toward diabetes care and why the pharmacist's role has never been more important.

Diabetes technology is changing the way people monitor blood sugar, take insulin and manage daily life. In this episode, Caitlin Nass, CRNP, a diabetes expert and Clinical Director of the Diabetes Transformation program at UM Baltimore Washington Medical Center, explains how tools like continuous glucose monitors, insulin pumps and apps can help — and what patients should know about affordability, support and working with their care team.

We have only recently become aware of the close relationship between the heart and the kidneys. In today's discussion, Dr. Neil Skolnik speaks with Dr. Josephine Harrington to gain insight into these newly-discovered links between cardiovascular risk and CKD. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: -Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health -Josephine Harrington, M.D., Assistant Professor of Medicine in the Division of Cardiology at the University of Colorado School of Medicine. Selected references: -Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 -Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020;383:2219-2229 -Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020;383:1436-1446 -Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024;391:109-121

Stavros Nicolaou – Senior executive for strategic trade, Aspen Pharmacare SAfm Market Update - Podcasts and live stream

Dr. Sarah Gebauer explains the mechanics of artificial intelligence in healthcare. We discuss neural networks, digital twins, FDA regulatory challenges, and practical ways to use AI for everyday tasks. ABLEnow save for today's needs or invest for tomorrow Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Welcome to the latest episode (May 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month, they discuss: Marston NA, Bohula EA, Bhatia AK, et al. "Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial." JAMA. 2026;335(16):1400–1407. doi:10.1001/jama.2026.3277 Lee YJ, Lee SJ, Kim JW, et al. "Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease." N Engl J Med 2026;394:1365-1375. doi:10.1056/NEJMoa2600283 Nissen SE, Wolski K, D'Alessio D, et al. "Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial." JAMA Cardiol. Published online March 28, 2026. doi:10.1001/jamacardio.2026.0767 Moura FA, et al. "Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis." Diabetes Care. 2026;49(5):724–729. doi.org/10.2337/dc25-1238 Ostrominski JW, Ortega-Montiel J, et al. "Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations." Diabetes Care. 2026;49(5):808–817 doi.org/10.2337/dc25-3063 Nicole Napoli, "Shingles Vaccine Drastically Cuts Risk of Serious Cardiac Events." The American College of Cardiology. March 17, 2026 https://www.acc.org/About-ACC/Press-Releases/2026/03/16/19/33/Shingles-Vaccine-Drastically-Cuts-Risk-of-Serious-Cardiac-Events For information about the American Diabetes Association's scholarly journals, visit diabetesjournals.org. For more about this podcast, visit About Diabetes Core Update.

During the live phone-in programme “Hello Doctor” on Akashvani, the discussion highlighted the strong link between obesity, diabetes, and insulin resistance, etc. emphasizing that diabetes management should go beyond just controlling blood sugar. Experts stressed that focusing only on glucose levels (a “glucocentric approach”) is not enough; instead, a holistic approach is essential, including weight control, lifestyle changes, and overall metabolic health. It was explained that obesity—especially central or abdominal obesity (visceral fat)—plays a major role in increasing insulin resistance. Fat accumulation around vital organs such as the liver, pancreas, kidneys, and heart leads to chronic inflammation, which is the root cause of many complications including heart disease, stroke, kidney damage, neuropathy, and gangrene etc. Even individuals with normal weight but increased waist circumference are at higher risk. The session also highlighted that increasing body fat reduces the effectiveness of insulin, leading to higher insulin levels (hyperinsulinemia) and eventually exhausting insulin-producing beta cells. This contributes to the development and progression of Type 2 diabetes. Clear targets for blood sugar control were discussed for different age groups, along with the importance of avoiding hypoglycemia, especially in elderly individuals. The role of continuous glucose monitoring (CGM) and “time in range” was also explained as a modern approach to diabetes care. The key message was: control weight, reduce abdominal fat, follow regular meal timing, stay active, and adopt preventive healthcare practices to effectively manage and prevent diabetes and its complications. Expert: Dr Sunil Gupta Anchor: Purva Kulkari Podcast : 27/03/2026 Recorded at: Akashwani Nagpur

Resources and References Action Steps to Build AI Acumen Handout Deep Medicine, Dr. Eric Topol Arcadia. The Art of AI. Blending Innovation with Know-How in Healthcare, October 2025. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcastLearn more about ADCES and the many benefits of membership at adces.org/join.The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Die meisten Ratgeber beruhen auf Stress-Forschung aus den 90ern – und wurden für 30-Jährige geschrieben. Kein Wunder, dass die alte Cortisol-Formel ab 40 nicht mehr zu funktionieren scheint.In dieser Folge erfährst Du, wie chronischer Stress Dein Hormonsystem ab 40 aus dem Takt bringt, warum Östrogen und Testosteron als natürliche Stresspuffer schwächer werden – und warum die gleiche Belastung Dich mit 45 messbar härter trifft als mit 30.Dazu bekommst Du fünf evidenzbasierte Werkzeuge, die Du noch diese Woche umsetzen kannst. Eins davon kostet Dich fünf Minuten am Tag. Eins brauchst Du nur, wenn Du in der Mittagspause ohnehin essen willst. Und eins ist das am besten dokumentierte Anti-Stress-Werkzeug der letzten zehn Jahre – obwohl es fast nie in Stress-Ratgebern auftaucht.Diese Folge ist für Dich, wenn Du wissen willst, was sich an Deinem Körper ab 40 wirklich verändert – und was konkret dagegen hilft.____________*WERBUNG: Infos zum Werbepartner dieser Folge und allen weiteren Werbepartnern findest Du hier.____________

Most organizations put "Collaboration" on a wall. Few actually live it — and in healthcare, the cost of not living it isn't a missed deadline. It's a missed patient. In the first episode of Your Health University's brand-new Most organizations put "collaboration" on a wall. Few actually live it — and in healthcare, the cost of not living it isn't a missed deadline. It's a missed patient. In the first episode of Your Health University's brand-new Our Values Series, host Jamie Preston gathers four members of Your Health's patient experience team — Rebecca Dillard (VP of Organizational Experience), Jennifer Kessler (Division President of Product), Whitney Myers (Senior Solutions Advisor), and Carlos Hayward (Business Office Manager) — for an unfiltered conversation about what genuine collaboration looks like inside a fast-moving, mission-driven healthcare organization. No theory. No platitudes. Just the real, messy, mundane, and occasionally remarkable daily practice of people choosing to work together when it would be easier to go it alone. What you'll hear in this episode: Why real collaboration means recognizing what the person next to you brings that you simply cannot replicate — and building toward that, not around it The true story of a patient found living in an RV without his medication — and how cross-team collaboration made the difference between crisis and care Where collaboration most commonly breaks down in healthcare settings, and the small documentation and communication habits that prevent it The one question — "How can I do my job differently to make yours better?" — that builds trust across departments faster than almost anything else The daily habits these four healthcare professionals actually practice to keep collaboration alive, from weekly team check-ins to learning someone's preferred communication style before you assume Collaboration isn't a value you perform. It's a choice you make — one conversation, one phone call, one honest mistake admitted at a time. Values Series, host Jamie Preston gathers four members of Your Health's patient experience team — Rebecca Dillard (VP of Organizational Experience), Jennifer Kessler (Division President of Product), Whitney Myers (Senior Solutions Advisor), and Carlos Hayward (Business Office Manager) — for an unfiltered conversation about what genuine collaboration looks like inside a fast-moving, mission-driven healthcare organization. No theory. No platitudes. Just the real, messy, mundane, and occasionally remarkable daily practice of people choosing to work together when it would be easier to go it alone. What you'll hear in this episode: Why real collaboration means recognizing what the person next to you brings that you simply cannot replicate — and building toward that, not around it The true story of a patient found living in an RV without his medication — and how cross-team collaboration made the difference between crisis and care Where collaboration most commonly breaks down in healthcare settings, and the small documentation and communication habits that prevent it The one question — "How can I do my job differently to make yours better?" — that builds trust across departments faster than almost anything else The daily habits these four healthcare professionals actually practice to keep collaboration alive, from weekly team check-ins to learning someone's preferred communication style before you assume Collaboration isn't a value you perform. It's a choice you make — one conversation, one phone call, one honest mistake admitted at a time. www.YourHealth.Org

Send us Fan MailWhat if food worked better than medication for managing diabetes?In this clip from our episode “Food As Medicine: From Trend to Treatment”, CareTalk host John Driscoll and guest Spencer Pratt, Chief Growth Officer at NourishedRx, share the clinical data behind their food as medicine approach to diabetes care.

In this special edition on Continuous Ketone Monitoring our host, Dr. Neil Skolnik will discuss this new technology – its promise and its application. This special episode is supported by an independent educational grant from Abbott. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Guillermo Umpierrez, M.D.,  Professor of Medicine, Division of Endocrinology, Clinical Director of the Diabetes and Metabolism Center at Emory University School of Medicine, Director of the Diabetes and Endocrinology Section and Clinical Research Unit at Grady Memorial Hospital, Atlanta, Georgia. Member of the ADA Professional Practice Recommendation Committee, and Chair of the ADA Consensus Report on Hyperglycemic Crises in Adults with Diabetes.   Reference: Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257–1275 | https://doi.org/10.2337/dci24-0032

Modern medicine has come a long way in its fight against diabetes. We now have continuous glucose monitors (CGM) and automated insulin delivery (AIDs) systems. These have revolutionized patient care. The FDA has approved devices for use in pregnancy as “nonadjunctive use” (meaning they may be used alone), although capillary finger stick assessments are currently still considered the Gold Standard. While the most robust data in support of CGMs is for preexisting Type 1 DM (Class B or beyond) and Type 2, there is recent growing support for CGM use in GDM patients, although some limitations still apply. Listen in for details.1. Feig DS, et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. 2. Benhalima K, Durnwald C, Sweeting A et al.Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statementThe Lancet Diabetes & Endocrinology, 2025; 14, 157-1773. Salmen BM, Reurean-Pintilei D, Salmen T, Bohîlțea RE. Exploring Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review. Life (Basel). 2025 Aug 28;15(9):1369. doi: 10.3390/life15091369. PMID: 41010309; PMCID: PMC12470761.4. Wyckoff JA, Lapolla A, Asias-Dinh BD, et al.Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 20255. American Diabetes Association Professional Practice Committee for Diabetes*; 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026. Diabetes Care 1 January 2026; 49 (Supplement_1): S321–S338. https://doi.org/10.2337/dc26-S0156. Burk J, Ross GP, Hernandez TL, Colagiuri S, Sweeting A. Evidence for improved glucose metrics and perinatal outcomes with continuous glucose monitoring compared to self-monitoring in diabetes during pregnancy. Am J Obstet Gynecol. 2025 Sep;233(3):162-175. doi: 10.1016/j.ajog.2025.04.010. Epub 2025 Apr 10. PMID: 40216177.7. Linder T, et al; GRACE study collaborative group. Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial. Lancet Diabetes Endocrinol. 2026 Jan;14(1):50-61. doi: 10.1016/S2213-8587(25)00288-8. Epub 2025 Nov 24. PMID: 41308662.8. Valent AM, et al. Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Diabetes Care. 2025 Sep 1;48(9):1581-1588. doi: 10.2337/dc25-0115. PMID: 40730104; PMCID: PMC12368369.9. Kusinski LC, et al. Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial. Diabetes Care. 2025 Aug 19:dc250452. doi: 10.2337/dc25-0452. Epub ahead of print. PMID: 40828742; PMCID: PMC7618813.10. García-Moreno RM, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022 Jan;39(1):e14703. doi: 10.1111/dme.14703. Epub 2021 Oct 13. PMID: 34564868.11. Amylidi-Mohr Set,.et al (DipGluMo): an open-label, single-centre, randomised, controlled trial. Lancet Diabetes Endocrinol. 2025 Jul;13(7):591-599. doi: 10.1016/S2213-8587(25)00063-4. Epub 2025 May 26. Erratum in: Lancet Diabetes Endocrinol. 2026 Mar;14(3):e6. doi: 10.1016/S2213-8587(25)00403-6. PMID: 40441173.

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence. Key Concepts A few existing agents now have ASCVD risk reduction data in patients with existing ASCVD or high indicators for ASCVD. They are: oral semaglutide and tirzepatide.  SGLT2is are still first-line in patients with diabetes and HF including HFpEF, but SC semaglutide and tirzepatide are now recommended for those with symptomatic HFpEF and obesity due to positive outcomes in this population. The GLP-1RA and dual GLP-1/GIP RA are the preferred agents for weight management in patients with T2DM, but use of GLP-1RA can be considered for weight loss in patients with T1DM. The guideline also better defines recommendations for medication-induced hyperglycemia from immune checkpoint inhibitors, PI3Kɑ (phosphoinositidylinositol 3-kinase α) inhibitors, mTOR inhibitors, and steroids.  References American Diabetes Association. Standards of care in diabetes—2026. Diabetes Care. 2026;49(suppl 1):S1-S377. SOUL study. Darren K. McGuire, Marx N, Mulvagh SL, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes. N Engl J Med. 2025;392(20):2001-2012. doi:10.1056/NEJMoa2501006. SURPASS-CVOT. Nicholls SJ, Pavo I, Bhatt DL, et al. Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes. N Engl J Med. 2025;393(24):2409-2420. doi:10.1056/NEJMoa2505928. SUMMIT. Packer M, Zile MR, Kramer CM, et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med. 2025;392(5):427-437. doi:10.1056/NEJMoa2410027. STEP-HFpEF. Kosiborod MN, Abildstrom SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. doi:10.1056/NEJMoa2306963. STEP-HFpEF DM. Kosiborod MN, Petrie MC, Borlaug BA, et al. Semaglutide in patients with obesity‑related heart failure and type 2 diabetes. N Engl J Med. 2024;390(15):1394‑1407. doi:10.1056/NEJMoa2313917.

Send us Fan MailFood as medicine is moving from buzzword to real healthcare strategy.In this CareTalk episode, Spencer Pratt, Chief Growth Officer of NourishedRx, explains why nutrition is finally getting the policy, payer, and consumer support needed to impact chronic disease at scale.

This issue will review: 1.     Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide 2.     Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the U.S. General Population 3.     Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes 4.     Finerenone in Type 1 Diabetes and Chronic Kidney Disease 5.     Effects of Sodium/Glucose Cotransporter-2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's science and medical journals – Diabetes, Diabetes Care, and Diabetes, Obesity, and Cardiometabolic CARE, and beyond. Each episode is approximately 25 minutes long and presents recently published articles from ADA journals and more. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

This week, Tee welcomes Dr. Paul Dabney, NMD, MPH, M.Ed., a naturopathic physician and CEO of The Center for Natural Health and Optimal Wellness, for a conversation on rethinking diabetes care through prevention and integrative medicine. With over 20 years of experience in clinical research, medical writing, and public health, his work has included contributions to The Centers for Disease Control and Prevention, The Food and Drug Administration, Michigan State University School of Veterinary Medicine, and The U.S. Army Medical Corps, along with teaching roles in naturopathic education. In this episode, Dr. Paul shares how his path into naturopathic medicine was shaped by both scientific training and personal heritage. Drawing from his background in microbiology, antimicrobial resistance, and public health, along with his mother's Cherokee-based healing traditions, he offers a perspective that bridges conventional and holistic care.  Throughout the conversation, Dr. Paul emphasizes that while medications can be helpful, they may also contribute to nutrient depletion or unintended side effects in some cases. He highlights the importance of key nutrients such as zinc, vitamin D, magnesium, and vitamin B6, along with foundational lifestyle factors like sleep, stress management, cortisol balance, and access to quality food. He also shares practical strategies to support blood sugar stability, including simple combinations like pairing fruit with proteins and healthy fats. This episode reinforces that lasting health comes from consistent, informed choices. If you are looking to take a more proactive approach to your health, this conversation offers both clarity and actionable steps. Connect with Dr. Paul: Website LinkedIn  Facebook  Instagram Dr. Paul is offering a 15% discount on the first 1-hour of consultation. Just mention the code Green Tee when you call his office @ (706) 244-4948    Follow Therese "Tee" Forton-Barnes and The Green Living Gurus: Austin Air Purifiers: For podcast listeners, take 15% off any Austin Air product; please email Tee@thegreenlivinggurus.com and mention that you want to buy a product and would like the discount. See all products here: Austin Air   The Green Living Gurus' Website  Instagram YouTube Facebook Healthy Living Group on Facebook   Tip the podcaster! Support Tee and the endless information that she provides: Patreon Venmo: @Therese-Forton-Barnes last four digits of her cell are 8868 For further info, contact Tee: Email: Tee@thegreenlivinggurus.com Cell: 716-868-8868   DISCLAIMER: ALL INFORMATION PROVIDED HERE IS GENERAL GUIDANCE AND NOT MEANT TO BE USED FOR INDIVIDUAL TREATMENT. PLEASE CONTACT YOUR PROVIDER OR DOCTOR FOR MEDICAL ADVICE.   Produced By: Social Chameleon

This special Diabetes Alert Day episode of the Quality Corner Show focuses on how pharmacy teams can move beyond dispensing to become proactive leaders in chronic disease management.Host Ashley Ramer, MSN,RN, is joined by Terilyn St. Pierre, BSN, RN, to discuss the critical role of Hemoglobin A1C testing in the pharmacy setting. With 1 in 10 U.S. adults living with diabetes, and many unaware of their status, the pharmacy serves as a frequent and accessible touchpoint for closing essential care gaps.In this episode, we cover the power of immediacy, clinical essentials, EQUIPP resources and a step by step demonstration. 

William A. Bryson, PharmD, joins Over the Counter for a bonus rendition celebrating Diabetes Alert Day on March 24.

During the live phone-in programme “Hello Doctor” on Akashvani, Dr. Sunil Gupta explained that diabetes can affect many organs of the body when blood sugar remains uncontrolled for a long time. One of the most common complications is diabetic neuropathy, a condition in which nerves are gradually damaged due to prolonged high blood glucose levels. This complication usually develops over several years and most often begins in the nerves of the feet and hands. Dr. Sunil Gupta stated that common symptoms of neuropathy include burning sensation, tingling, numbness, reduced sensation, and pain in the feet. Many patients may not notice minor injuries or wounds because of decreased sensitivity. Sometimes, even slippers may slip off while walking without the person realizing it. Due to this loss of sensation, the condition is often referred to as a “high-risk foot” situation. He further explained that if nerve damage is combined with poor blood circulation (neuro-ischemic foot), wound healing becomes slow and difficult. In severe cases, untreated wounds may lead to serious complications such as infection or gangrene, making it at high risk for amputation. Dr. Sunil Gupta also highlighted that diabetes affects both small blood vessels (microvascular disease) and large blood vessels (macrovascular disease), which can impact important organs such as the heart, kidneys, eyes, and feet. He emphasized that maintaining proper blood sugar control, regular medical check-ups, foot care, and early detection of complications are essential for preventing long-term damage and improving quality of life for people living with diabetes. Expert- Dr Sunil Gupta Anchor- Swati Huddar Podcast: 27/02/2026 Recorded at: Akashwani Nagpur

During the Akashvani live phone-in programme “Hello Doctor,” Dr. Sunil Gupta discussed various complications of diabetes and explained that the condition can affect almost every organ in the body. He highlighted that one of the most common and serious complications is diabetic neuropathy, a gradual damage to the nerves that develops over the natural course of the disease. Dr. Sunil Gupta explained that neuropathy usually begins in the nerves of the feet and hands. Common symptoms include burning sensation, tingling, numbness, reduced sensation, slippers slipping off while walking without noticing, and unrecognized wounds. This condition is considered a “high-risk foot” state. If poor blood circulation is also present (neuro-ischemic foot), wound healing becomes difficult and, in severe cases, may lead to gangrene. He also emphasized that diabetes affects both small and large blood vessels (microvascular and macrovascular disease), thereby impacting the heart, kidneys, eyes, and feet. Expert- Dr Sunil Gupta Anchor- Kalyani Gokhale Podcast: 03/02/2026 Recorded at: Akashwani Nagpur

We all know how important mental health is but unless you are VERY lucky, you're on your own.  There are the rare programs out there for pediatric endocrinology and we've got one of the best Dr. Taylor Stephens is a pediatric psychologist with the Cleveland Clinic who specializes in pediatric endocrinology conditions. She's here to share what we can all do, right after diagnosis, and years later to support our kids and ourselves, if you're a caregiver or an adult living with type 1 This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Learn more about the Mental Health + Diabetes Conference here. Use promo code "dmhconnections" to save 15% off your ticket Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss epidemiology, pathophysiology and screening for CKD in People with Diabetes. This special episode is supported by an independent educational grant from Bayer. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Holly Kramer, M.D., Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago, past-president of the National Kidney Foundation, Editor-in-Chief of the National Kidney Foundation's journal,  Advances in Kidney Disease and Health (AKDH).   Selected references: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1) :S246–S260  

Diabetes care doesn't happen only in the clinic—it happens where people live, shop, and eat. This episode explores why food access, community support, and real-world resources matter just as much as medical care.We unpack how food insecurity and the digital divide affect diabetes management, where food-as-medicine programs can make a real difference, and how GLP-1 medications fit without replacing nutrition and behavior change. We also highlight one policy shift that could dramatically expand access to diabetes nutrition support.Guest Bio:Dr. Melanie Hingle is a nationally recognized nutrition scientist, registered dietitian, and Professor at the University of Arizona whose work on diet-sensitive disease integrates community-engaged research, digital health, and Food As Medicine interventions across the Southwest. Quote:“Fresh produce, high in fiber, high in nutrients, these are things that help people manage, not just the blood glucose a little bit better, but can displace some of the less healthy options”Question of the Day:How might you help advocate for better nutrition support or diabetes resources in your community?On This Episode You Will Learn:Why community-based nutrition is essential for effective diabetes careHow food insecurity and access gaps directly shape diabetes outcomesWhat programs like produce prescriptions and medically tailored meals get rightHow to integrate GLP-1s with nutrition counseling without losing the food-first focusWhich policy and reimbursement changes could most effectively reduce diabetes disparitiesConnect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Dr. Melanie Hingle!University of Arizona Website Profile: https://profiles.arizona.edu/person/hinglemEmail: hinglem@arizona.edu

This issue will review: 1.     Real-World Prospective Validation and Economic Evaluation of Deep Learning-based Diabetic Retinopathy Detection from Fundus Photographs: A Systematic Review and Meta- Analysis 2.     Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial 3.     FDA removal of SI for GLP-1s – FDA Announcement Neil Read/John Comment 4.     Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk: A Target Trial Emulation Study 5.     GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients with Type 2 Diabetes or Cardiometabolic Diseases: A Meta-Analysis of Randomized Controlled Trials  Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss diagnosis and treatment of MASH using a case-based approach with two master clinicians, one a hepatologist and the other a primary care physician. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Alina M. Allen, M.D. Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. Susan Kuchera, M.D. - Program Director of the Jefferson Health Abington Family Medicine Residency Program, Clinical Associate Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082  

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Dr. Sahasranam: Emotional intelligence.Diabetes education saves lives, yet only 5 to 7 percent of people with diabetes ever receive it. This startling gap in care is the driving force behind My Diabetes Tutor, a telehealth platform founded by Dr. Prem Sahasranam. His mission? To make diabetes education accessible to everyone, regardless of geography or socioeconomic barriers.Dr. Sahasranam, a board-certified endocrinologist with nearly two decades of experience, explained how critical education is in diabetes management: “Studies have shown that just going through diabetes education reduces A1C by 0.73 points. At our program, our outcomes are two times better than the national average.” With over 9,000 patients served, My Diabetes Tutor consistently delivers remarkable results, achieving an average A1C reduction of 1.6 points—enough to significantly lower complications and mortality rates.The idea for My Diabetes Tutor was born out of necessity. Dr. Sahasranam shared a story about how two full-time diabetes educators in his rural California practice helped patients achieve exceptional outcomes. When they retired in 2018, he struggled to recruit replacements, a problem endemic to underserved areas. “I decided to build a telehealth program,” he said. “My goal was to solve an access issue and deliver diabetes education to people, irrespective of their zip code or language.”My Diabetes Tutor provides nationally accredited virtual diabetes education, covering medical nutrition therapy, continuous glucose monitoring, insulin pump training, and more. The platform recently launched the first-ever pediatric diabetes education program, a groundbreaking step toward addressing the needs of young patients.Dr. Sahasranam's vision extends beyond patient outcomes to include investor participation. My Diabetes Tutor is currently raising capital through a regulated crowdfunding campaign on StartEngine. “I want investors to own a piece of our growth and be part of our journey,” he said. The company generated over $2 million in revenue last year with a 61 percent gross margin, demonstrating both impact and financial viability.Dr. Sahasranam's work is not just about business; it's a mission to transform lives. By breaking down barriers to education, he's giving people the tools to manage their diabetes effectively, live healthier lives, and reduce complications.For those looking to make a difference—or simply to invest in a business delivering measurable impact—My Diabetes Tutor offers a unique opportunity.tl;dr:Dr. Prem Sahasranam founded My Diabetes Tutor to provide virtual education for diabetes management.The program addresses barriers to care in underserved communities by delivering telehealth services nationwide.My Diabetes Tutor achieves outcomes twice as effective as national averages in reducing A1C levels.The company generated over $2 million in 2025 and is raising capital via StartEngine crowdfunding.Prem credits emotional intelligence as his superpower, driving his mission to revolutionize diabetes care.How to Develop Emotional Intelligence As a SuperpowerDr. Prem describes his superpower as emotional intelligence, honed through years of experience as a board-certified endocrinologist. He explained, “Most health systems focus on the biology of the disease and fail to address the human part.” By understanding the emotional and practical needs of patients, Prem has created innovative solutions to improve access to diabetes education. He added, “I learned from my experience and built the right team, content, and technology to bring in diabetes education, easily accessible for patients.”Prem shared a pivotal story of a patient who had been struggling to control their diabetes despite receiving appropriate medications. The patient hesitated to make a two-hour drive to see Prem but eventually visited his practice and met with a diabetes educator. Without altering the patient's medications, the educator provided tailored guidance that helped the patient manage their condition. This experience inspired Prem to create My Diabetes Tutor, ensuring patients could access life-changing education from their own homes.Tips for Developing Emotional Intelligence:Reflect on past experiences to identify unmet needs and learn from them.Stay aware of the human challenges behind systemic issues.Focus on creating solutions that address both emotional and practical barriers.Build strong, empathetic teams that align with your mission.By following Dr. Prem's example and advice, you can make emotional intelligence a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Get Your Copy!Guest ProfileDr. Prem Sahasranam (he/him):Founder, CEO, and Chief Medical Officer, My Diabetes Tutor (MDT)About My Diabetes Tutor (MDT): My Diabetes Tutor (MDT) is an ADCES-accredited telehealth service that provides comprehensive Diabetes Self-Management Education and Support (DSMES) via virtual, 1-on-1 sessions with Certified Diabetes Care and Education Specialists (CDCES). We bridge the gap for the 93% of eligible patients who currently do not utilize DSMES due to access barriers. We accept Medicare, Medicaid, and most private insurance (often with $0 out-of-pocket for patients). Participants achieve an average 1.6 pt reduction in A1C, 2x the national average for diabetes education.Website: mydiabetestutor.comCompany Facebook Page: facebook.com/mydiabetestutorInstagram Handle: @mydiabetestutor_Other URL: startengine.com/offering/my-diabetes-healthBiographical Information: Prem Sahasranam, MD (Dr. Sahas) is a Board-Certified Endocrinologist with over 20 years of clinical experience. He founded My Diabetes Tutor in 2019 to address the critical shortage of specialists in rural “care deserts”. A graduate of Madras Medical College with post-graduate training at Cornell University's Weill Medical College, he is currently an Assistant Clinical Professor at Loma Linda University and a dedicated advocate for health equity.LinkedIn Profile: linkedin.com/in/prem-sahasranam-ba10077Personal Facebook Profile: facebook.com/PremsahasranamThe Super Crowd, Inc., a public benefit corporation, is proud to have been named a finalist in the media category of the impact-focused, global Bold Awards.Support Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include rHealth, and Make Money with Impact Crowdfunding. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Nick Degnan, Unlimit Ventures | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on February 17th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details. Upgrade to Impact Membership today!SuperCrowdHour February: This month, Devin Thorpe will be digging deep into my core finance expertise to share guidance on projections and financial statements. We're calling it “Show Me the Numbers: Building Trust with Financial Clarity.” Register free to get all the details. February 18th at Noon ET/9:00 PT.Superpowers for Good Live Pitch: The top-raising Reg CF campaign of 2025 won the June 2025 Superpowers for Good Live Pitch. We're taking applications for the March 17, 2026, Live Pitch now. There is no fee to apply and no fee to pitch if selected! Apply here now!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Dr. Carol Johnston—Arizona State University nutrition professor and registered dietitian known online as “The Vinegar Lady”—joins Rob to break down what decades of research actually say about vinegar, blood glucose, and metabolic health. Johnston explains how her work began with an obscure 1988 rat study and led to a landmark 2004 Diabetes Care paper showing vinegar could blunt post-meal blood glucose spikes in people without diabetes, those with pre-diabetes, and those with type 2 diabetes. They dig into why vinegar still gets treated like “fringe” advice despite strong replication across countries—and why the mechanism overlaps with a major target of metformin. The conversation gets highly practical: why liquid vinegar matters (pills don't), how timing at the start of a meal changes outcomes, and the two core mechanisms—reduced starch digestion plus increased glucose uptake into muscle via GLUT4, similar to the effect of post-meal walking. Johnston also connects vinegar to the gut microbiome and acetate's growing role in brain and energy metabolism, sharing her own routine (on vegetables) and emerging findings on cognitive/depression measures supported by metabolomics. You'll also hear real-world implementations like homemade vinaigrettes (flip the ratio to 2:1 vinegar to oil), mustard as a stealth vinegar vehicle, and even “pickle sickles,” plus safety notes around dilution, enamel, and gastroparesis risk. Chapters: 00:01 Intro: “The Vinegar Lady” + why vinegar is on the table for diabetes 01:35 Johnston's background + why she studies simple, sustainable nutrition strategies 03:03 The 1988 rat study discovery → the first human trials with bagels + vinegar 04:32 Publishing in Diabetes Care (2004) + replication across the world 05:53 Why clinicians resist vinegar (“we have drugs for this”) + metformin overlap 10:28 Acetic acid, fermentation, and the gut microbiome connection (why it matters) 14:04 The two key mechanisms: starch digestion interference + faster muscle glucose uptake 22:46 Practical + safety: pills don't work, dilution, enamel/aspiration risk, timing with meals 25:53 Johnston's personal protocol + brain/cognition/depression angle + metabolomics support 46:47 Athletic applications: pickle juice, “pickle sickles,” mustard hack + where research goes next

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode of The Healthy Diabetic Podcast, I sit down with Rachel Faber MS, RD, LDN, CDCES and Nicole Cordoba RN, CDCES, known online as CDE Diabuddies, to explore what diabetes care looks like when providers are also patients—and why pediatric diabetes care often feels worlds apart from adult care.Rachel and Nicole share their personal diagnosis stories—one diagnosed at age 4, the other at 17—and how those experiences shaped their paths into healthcare as Certified Diabetes Care and Education Specialists (CDCES). Together, they walk through what pediatric diabetes education which actually includes: multi-day hospital education, family involvement, hands-on insulin training, mental health screening, and structured follow-ups.The conversation dives deep into the systemic gaps that appear when patients transition into adult care, including shorter visits, less education, fewer resources, and limited emotional support. Ken and the guests discuss misdiagnosis, insurance barriers, Dexcom-induced anxiety, parental dynamics, and why flexibility—not rigidity—is key to long-term diabetes success.

How can AID close gaps in T2D care and help you personalize evidence-based AID for real-world practice? Credit available for this activity expires: 1/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/utilizing-automated-insulin-delivery-close-gaps-type-2-2026a10002xh?ecd=bdc_podcast_libsyn_mscpedu

This issue will review: 1.     Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial 2.     Impact of Oral Semaglutide on Kidney Outcomes in People with Type 2 Diabetes: Results from the SOUL Randomized Trial 3.     The effect of substituting water for artificially sweetened beverages on glycemic and weight measures in people with type 2 diabetes: The Study of Drinks with Artificial Sweeteners (SODAS), a randomized trial 4.     Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: a meta-analysis of randomized trials Trial Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let's talk about what's changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/  

In this Christmas Eve episode, Jess and Wendy chat with dietitian Krystal Martinez to debunk a major diabetes myth: that you have to give up your cultural foods to manage blood sugar. Krystal, a first-generation Mexican-American specializing in prediabetes and type 2 diabetes, shares why staples like tortillas, rice, and beans belong on your plate. She offers practical tips for balancing meals during the holidays and beyond, covering portions, protein, fiber, and healthy fats. We also go into the white vs. brown rice debate, the harm of cutting out entire food groups, and how to enjoy Nochebuena without guilt. Happy Holidays!If you're living with diabetes or prediabetes and want personalized support from a Registered Dietitian Nutritionist covered by insurance, visit diabetesdigital.co to connect with our culturally aware and weight-inclusive team. And if you love the show, don't forget to rate and review us on iTunes or Spotify—it makes a huge difference! For additional resources and show notes, head to diabetesdigital.co/podcast.

Scott and Jenny discuss bolusing for Sonic Tater Tots Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of DPAC, the Diabetes Patient Advocacy Coalition. We've got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you've ever thought your voice doesn't matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections. Keywords Diabetes, D-PAC, Medicare, GLP-1 medications, patient advocacy, healthcare access, insulin pumps, CGMs, diabetes technology, legislative reform AI info below: Summary In this conversation, George Huntley, CEO of the Diabetes Patient Advocacy Coalition (D-PAC), discusses the critical role of advocacy in improving diabetes care and access to technology. He highlights the challenges faced by patients, particularly regarding Medicare coverage for insulin pumps and continuous glucose monitors (CGMs), and the implications of recent legislative changes. The discussion also covers the potential of GLP-1 medications in diabetes management and the importance of patient stories in advocacy efforts. Takeaways D-PAC focuses on affordable and equitable access to diabetes care. Advocacy is crucial for influencing healthcare policies. Competitive bidding for diabetes technology could limit access for seniors. Patient stories are essential in legislative advocacy. GLP-1 medications show promise in reshaping diabetes treatment. Economic factors play a significant role in healthcare access. The aging population of type 1 diabetes patients requires urgent attention. Collaboration among advocacy groups is vital for success. Healthcare costs are driven more by major medical expenses than by drug prices. Continued advocacy is necessary to protect patient access to care. Chapters 00:00 Introduction to Diabetes Advocacy 03:01 The Role of D-PAC in Diabetes Care 05:53 Challenges in Medicare Coverage for Diabetes Technology 09:11 The Impact of Competitive Bidding on Seniors 11:55 Advocacy Efforts and Legislative Challenges 14:57 The Future of GLP-1 Medications 17:56 Economic Implications of Diabetes Management 21:01 The Importance of Patient Advocacy 23:59 Healthcare Costs and Insurance Dynamics 26:56 The Need for Continued Advocacy 29:54 Conclusion and Call to Action

Dr. Michael Snyder joins Dr. Forbes to discuss research showing that Type 2 diabetes represents multiple metabolic subtypes rather than a single condition. He explains how glucose curve patterns, oral glucose tolerance testing, and continuous monitoring can help identify differences in muscle insulin resistance, beta-cell function, hepatic signaling, and incretin response. The conversation explores how these physiological patterns may guide individualized nutrition strategies, medication selection, and earlier detection in people with emerging dysregulation.